Chenxi Qu
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
-
- Nanoplatforms for cancer theranostics
- 3D Printing in Biomedical Research
Papers in
-
- Nanoparticle-Based Drug Delivery 6
-
- RNA Interference and Gene Delivery 3
- Advanced biosensing and bioanalysis techniques 1
- Signaling Pathways in Disease 1
- Bioactive Natural Diterpenoids Research 1
- Co-authors
- Xuenong Zhang (8 shared papers)Bengang You (7 shared papers)Shu-di Yang (7 shared papers)Fang Li (4 shared papers)Mengtian Chen (3 shared papers)Dandan Wang (3 shared papers)Jizhao Li (3 shared papers)Zhi-qiang Yuan (3 shared papers)
- Journals
- ACS Applied Materials & Interfaces (2 papers)Molecular Pharmaceutics (1 paper)Acta Biomaterialia (1 paper)International Journal of Pharmaceutics (1 paper)Theranostics (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Chenxi Qu
10 papers receiving 445 citations
Peers
Comparison fields: 5 of 78
- Biomaterials 206
- Biomedical Engineering 211
- Pharmaceutical Science 23
- Cancer Research 48
- Molecular Biology 213
Countries citing papers authored by Chenxi Qu
This map shows the geographic impact of Chenxi Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenxi Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenxi Qu more than expected).
Fields of papers citing papers by Chenxi Qu
This network shows the impact of papers produced by Chenxi Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenxi Qu. The network helps show where Chenxi Qu may publish in the future.
Co-authors
The 25 scholars most cited alongside Chenxi Qu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 87 | |
| 2 | 2016 | 72 | |
| 3 | 2017 | 54 | |
| 4 | 2018 | 53 | |
| 5 | 2019 | 51 | |
| 6 | 2017 | 50 | |
| 7 | 2018 | 44 | |
| 8 | 2018 | 27 | |
| 9 | 2022 | 6 | |
| 10 | 2013 | 3 |
About Chenxi Qu
Chenxi Qu is a scholar working on Biomaterials, Molecular Biology, Biomedical Engineering, Organic Chemistry and Urology, having authored 10 papers that have together received 447 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (6 papers), Nanoplatforms for cancer theranostics (4 papers), RNA Interference and Gene Delivery (3 papers), Advanced biosensing and bioanalysis techniques (1 paper), Signaling Pathways in Disease (1 paper), Graphene and Nanomaterials Applications (1 paper), Bioactive Natural Diterpenoids Research (1 paper) and Computational Drug Discovery Methods (1 paper). The work is most often cited by research in Biomaterials (206 citations), Biomedical Engineering (211 citations), Pharmaceutical Science (23 citations), Cancer Research (48 citations) and Molecular Biology (213 citations). Chenxi Qu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xuenong Zhang, Bengang You, Shu-di Yang, Fang Li, Mengtian Chen, Dandan Wang, Jizhao Li, Zhi-qiang Yuan, Weiliang Chen and Wei‐Liang Chen. Their work appears in journals such as ACS Applied Materials & Interfaces, Molecular Pharmaceutics, Acta Biomaterialia, International Journal of Pharmaceutics and Theranostics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.